The decision in focus
CoreAge Rx
Compounded semaglutide with no separate membership advertised. Public $79 and $99 displays need reconciliation; complete renewal cost remains unknown.
Side by side
Compare CoreAge’s unresolved starting prices with Mochi membership and medication costs, while keeping compounded product status explicit.
The decision in focus
Compounded semaglutide with no separate membership advertised. Public $79 and $99 displays need reconciliation; complete renewal cost remains unknown.
The decision in focus
A mixed approved-and-compounded menu with $79 advertised membership. Medication and diagnostic costs are separate; promotional conditions require confirmation.
Mochi’s advertised $79 is a membership component. CoreAge’s $79 product-page figure is a starting medication offer that conflicts with a $99 navigation display. Matching those numerals would compare different purchases and ignore unresolved terms. We cannot name a cheaper complete option from these public figures.
CoreAge’s reviewed pathway is compounded semaglutide. Mochi lists a broader range of approved and compounded products. If you are discussing an approved branded product with a clinician, the reviewed CoreAge preparation is not an interchangeable substitute. Compounded drugs are not FDA-approved; the shared ingredient name cannot establish the same finished product or evidence.
Ask for a written quote that reconciles the two displayed prices and names the preparation, amount supplied and billing interval. Confirm whether clinical assessment and repeat prescription reviews are included, and what remains payable if no prescription is issued. Also identify which clinical questions go to the prescriber rather than general support.
Request membership, medication and diagnostic charges together. A free introductory membership offer can still come with medication purchase conditions, so ask for the minimum obligation and renewal schedule. Confirm the exact preparation and pharmacy, especially when an oral or compounded option is proposed. Do not add an advertised product minimum to membership and call the result a verified total.
If your clinician identifies a product available through only one of the compared routes, the fee comparison becomes secondary. If both routes are relevant, compare written ongoing quotes and usable clinical follow-up. A fee structure with fewer lines is easier to read, but clarity about prescription review, refills and cancellation is what makes it useful.
We use public information, have not enrolled as patients and do not measure clinical quality or support speed. Individual eligibility, state access, prescription and current terms must be confirmed directly.
Compounded drugs are not FDA-approved. This comparison is not a treatment recommendation. See our commercial disclosure and comparison method.